These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 31599401

  • 1. LncRNA GAS5 overexpression alleviates the development of osteoporosis through promoting osteogenic differentiation of MSCs via targeting microRNA-498 to regulate RUNX2.
    Feng J, Wang JX, Li CH.
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7757-7765. PubMed ID: 31599401
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-579-3p promotes the progression of osteoporosis by inhibiting osteogenic differentiation of mesenchymal stem cells through regulating Sirt1.
    Luo B, Yang JF, Wang YH, Qu GB, Hao PD, Zeng ZJ, Yuan J, Yang R, Yuan Y.
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6791-6799. PubMed ID: 31486477
    [Abstract] [Full Text] [Related]

  • 3. MiRNA-19a-3p alleviates the progression of osteoporosis by targeting HDAC4 to promote the osteogenic differentiation of hMSCs.
    Chen R, Qiu H, Tong Y, Liao F, Hu X, Qiu Y, Liao Y.
    Biochem Biophys Res Commun; 2019 Aug 27; 516(3):666-672. PubMed ID: 31248594
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-1286 inhibits osteogenic differentiation of mesenchymal stem cells to promote the progression of osteoporosis via regulating FZD4 expression.
    Zhou JG, Hua Y, Liu SW, Hu WQ, Qian R, Xiong L.
    Eur Rev Med Pharmacol Sci; 2020 Jan 27; 24(1):1-10. PubMed ID: 31957812
    [Abstract] [Full Text] [Related]

  • 5. Teriparatide alleviates osteoporosis by promoting osteogenic differentiation of hMSCs via miR-375/RUNX2 axis.
    Lei NB, Liang X, Wang P, Liu Q, Wang WG.
    Eur Rev Med Pharmacol Sci; 2019 Dec 27; 23(24):11043-11050. PubMed ID: 31858576
    [Abstract] [Full Text] [Related]

  • 6. LncRNA XIXT promotes osteogenic differentiation of bone mesenchymal stem cells and alleviates osteoporosis progression by targeting miRNA-30a-5p.
    Zhang HL, Du XY, Dong QR.
    Eur Rev Med Pharmacol Sci; 2019 Oct 27; 23(20):8721-8729. PubMed ID: 31696458
    [Abstract] [Full Text] [Related]

  • 7. Bone marrow stem cells-derived exosomes extracted from osteoporosis patients inhibit osteogenesis via microRNA-21/SMAD7.
    Jiang LB, Tian L, Zhang CG.
    Eur Rev Med Pharmacol Sci; 2018 Oct 27; 22(19):6221-6229. PubMed ID: 30338786
    [Abstract] [Full Text] [Related]

  • 8. LncRNA TERC alleviates the progression of osteoporosis by absorbing miRNA-217 to upregulate RUNX2.
    Gao GC, Yang DW, Liu W.
    Eur Rev Med Pharmacol Sci; 2020 Jan 27; 24(2):526-534. PubMed ID: 32016954
    [Abstract] [Full Text] [Related]

  • 9. MiRNA-365a-3p promotes the progression of osteoporosis by inhibiting osteogenic differentiation via targeting RUNX2.
    Cheng F, Yang MM, Yang RH.
    Eur Rev Med Pharmacol Sci; 2019 Sep 27; 23(18):7766-7774. PubMed ID: 31599402
    [Abstract] [Full Text] [Related]

  • 10. microRNA-1297 promotes the progression of osteoporosis through regulation of osteogenesis of bone marrow mesenchymal stem cells by targeting WNT5A.
    Wang Q, Wang CH, Meng Y.
    Eur Rev Med Pharmacol Sci; 2019 Jun 27; 23(11):4541-4550. PubMed ID: 31210281
    [Abstract] [Full Text] [Related]

  • 11. CircRUNX2 through has-miR-203 regulates RUNX2 to prevent osteoporosis.
    Yin Q, Wang J, Fu Q, Gu S, Rui Y.
    J Cell Mol Med; 2018 Dec 27; 22(12):6112-6121. PubMed ID: 30324718
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. MicroRNA-200a-3p accelerates the progression of osteoporosis by targeting glutaminase to inhibit osteogenic differentiation of bone marrow mesenchymal stem cells.
    Lv R, Pan X, Song L, Sun Q, Guo C, Zou S, Zhou Q.
    Biomed Pharmacother; 2019 Aug 27; 116():108960. PubMed ID: 31112871
    [Abstract] [Full Text] [Related]

  • 14. MiR-133 is Involved in Estrogen Deficiency-Induced Osteoporosis through Modulating Osteogenic Differentiation of Mesenchymal Stem Cells.
    Lv H, Sun Y, Zhang Y.
    Med Sci Monit; 2015 May 27; 21():1527-34. PubMed ID: 26013661
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Down-regulation of miR-339 promotes differentiation of BMSCs and alleviates osteoporosis by targeting DLX5.
    Zhou J, Nie H, Liu P, Wang Z, Yao B, Yang L.
    Eur Rev Med Pharmacol Sci; 2019 Jan 27; 23(1):29-36. PubMed ID: 30657543
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.